SUDAFED SINUS & ALLERGY OTC
Generic Name and Formulations:
Chlorpheniramine maleate 4mg, pseudoephedrine HCl 60mg; per tab.
McNeil Consumer Healthcare
Indications for SUDAFED SINUS & ALLERGY:
Rhinorrhea, nasal congestion, allergy symptoms.
1 tab every 4–6 hours as needed; max 4 doses/24hrs.
<6yrs: individualize. 6–11yrs: ½ tab every 4–6 hours as needed; max 4 doses/24hrs.
Within 14 days of MAOIs.
Cardiovascular disease. Hypertension. Thyroid disease. Glaucoma. Diabetes. GI or GU obstruction. Asthma. Lower respiratory disorders.
Hypertensive crisis with MAOIs. β-blockers may increase pressor response of sympathomimetics. Alcohol, other CNS depressants potentiated. Antagonizes antihypertensives.
Antihistamine + sympathomimetic.
Drowsiness, anticholinergic effects, nervousness, dizziness, insomnia, excitability in children.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|